Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has completed share repurchase transactions totaling DKK 120.5 million under its buy-back program, acquiring 664,764 shares at an average price of DKK 181.28. The company now holds 3,402,748 treasury shares representing 4.29% of share capital. Additionally, Health Canada approved the company's chikungunya vaccine VIMKUNYA®.